Related Experiment Video
Updated: Jan 25, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
Evaluation of Kagocel Genotoxicity.
A K Zhanataev1, T G Borovskaya2, B S Shcherbakova3
1V. V. Zakusov Research Institute of Pharmacology, Moscow, Russia. zhanataev@academpharm.ru.
The antiviral drug Kagocel was tested for genotoxicity. Kagocel did not induce gene mutations or chromosomal damage in various assays, indicating no genotoxic activity.
Area of Science:
- Pharmacology
- Toxicology
- Genetics
Background:
- Antiviral drugs require rigorous safety evaluation.
- Genotoxicity testing is crucial for assessing drug safety.
- Kagocel is an antiviral medication whose genotoxic potential needs to be understood.
Purpose of the Study:
- To evaluate the genotoxic activity of the antiviral drug Kagocel.
- To determine if Kagocel induces gene mutations or chromosomal damage.
Main Methods:
- Bacterial reverse mutation assay (Ames test) using Salmonella typhimurium strains and E. coli.
- In vivo chromosomal aberration test in mouse bone marrow cells.
- In vivo DNA comet assay in mouse testicular cells.
Main Results:
- Kagocel did not induce gene mutations in S. typhimurium or E. coli strains at tested concentrations.
- No significant increase in chromosomal aberrations was observed in mouse bone marrow cells.
- No significant increase in DNA breaks was detected in mouse testicular cells.
Conclusions:
- Kagocel exhibits no genotoxic activity in the studied dose range.
- The findings support the safety profile of Kagocel regarding genetic toxicity.
Related Concept Videos
Self-Evaluation: Self-Enhancement and Self-Verification
Nursing Evaluation
Self-Evaluation Maintenance Model
Dysrhythmias V: Evaluating Dysrhythmias
Social Foundations of Self III: Self-Evaluation
Heart Failure IV: Classification and Diagnostic Evaluation

